Indy

Market narrative

Read the headlines around the signals.

Move between stock news, official company releases, crypto, and FX without losing the path back to ticker research.

Latest prnewswire.com · about 9 hours ago

Enbridge Reports Strong Second Quarter Results, Reaffirms 2026 Guidance and Grows Secured Backlog to $41B

CALGARY, AB, July 31, 2026 /PRNewswire/ - Enbridge Inc. (Enbridge or the Company) (TSX: ENB) (NYSE: ENB) today reported second quarter 2026 financial results, reaffirmed its 2026 financial guidance and provided a quarterly business update. Highlights (All financial figures are unaudited and in Canadian dollars unless otherwise noted.

Read full story ↗ Research ENB

Press releases

More recent coverage

Page 14
NPRFF accessnewswire.com · about 9 hours ago

Nepra Foods Inc. Announces Filing of Annual Financial Statements and Management's Discussion and Analysis for the Year Ended March 31, 2026

CENTENNIAL, CO / ACCESS Newswire / July 31, 2026 / Nepra Foods Inc. (CSE: NPRA)(FSE: 2P6)(OTCQB: NPRFF) ("Nepra Foods" or the "Company"), a food and beverage company focused on product innovation, manufacturing and consumer wellness products, is pleased to announce that it has filed its audited annual financial statements, management's discussion and analysis ("MD&A"), and related CEO and CFO certifications (collectively, the "Annual Filings") for the fiscal year ended March 31, 2026. The Annual Filings have been filed on SEDAR+ and posted on the Canadian Securities Exchange ("CSE") and OTCQB websites.

Read source ↗
ATHA accessnewswire.com · about 9 hours ago

ATHA Energy Announces Election to Issue Common Shares in Satisfaction of US$25 Million Convertible Debenture Interest Payment Obligations

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESS Newswire / July 31, 2026 / ATHA Energy Corp. ("ATHA" or the "Company") (TSXV:SASK)(OTCQX:SASKF)(FRA:X5U) announces that in accordance with the terms of the US$25,000,000 twelve percent convertible debenture issued to Queen's Road Capital Investment Ltd. ("QRC") on February 5, 2026 (the "Convertible Debenture"), the Company has elected to issue 340,136 common shares in the capital of the Company ("Common Shares") at a deemed price of US$0.735 (C$1.031) to QRC as payment for US$249,999.96 (C$350,349.941) in interest owing on the Convertible Debenture.

Read source ↗
OTCM newsfilecorp.com · about 9 hours ago

American Tungsten Corp. Begins Trading on OTCQX Best Market

New York, New York--(Newsfile Corp. - July 31, 2026) - OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced American Tungsten Corp. (TSXV: TUNG) (OTCQX: TUNGF), a Canadian-based exploration and development company, has qualified to trade on the OTCQX® Best Market. American Tungsten Corp. upgraded to OTCQX from the OTCQB® Venture Market.

Read source ↗
AIBZ newsfilecorp.com · about 9 hours ago

Bitzero Announces Notice of Intention to Prepay Loan

Company expects to use a portion of financing proceeds to prepay existing secured indebtedness following five-business-day notice period Vancouver, British Columbia--(Newsfile Corp. - July 31, 2026) - Bitzero Holdings Inc. (NASDAQ: AIBZ) (CSE: AIBZ.U) (FSE: 000) ("Bitzero" or the "Company"), a provider of sustainable high-performance compute ("HPC") and AI data center infrastructure, announces that it has delivered the required notice under the Company's existing senior secured loan facility with a syndicate of lenders (the "Loan") of the Company's intention to prepay the outstanding obligations under the Loan. The Company expects to complete the prepayment on or about August 6, 2026, following expiry of the applicable five-business-day notice period under the Loan.

Read source ↗
INMB globenewswire.com · about 9 hours ago

INmune Bio Inc. to Report Second Quarter 2026 Financial Results and Provide Corporate Update on Thursday, August 6th

Management to host conference call and webcast at 4:30 pm ET on that day BOCA RATON, Fla, July 31, 2026 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a late-stage biotechnology company focused on inflammation and immunology, today announced t that it will host a conference call on Thursday, August 6th, 2026 at 4:30pm EDT to discuss results for its quarter ended June 30, 2026 and to provide a corporate update.  Conference Call Information To participate in this event, dial approximately 5 to 10 minutes before the beginning of the call.

Read source ↗
HOWL globenewswire.com · about 9 hours ago

Werewolf Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Updates

WATERTOWN, Mass., July 31, 2026 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions, today provided a business update and reported financial results for the second quarter ended June 30, 2026.

Read source ↗
TLSA globenewswire.com · about 9 hours ago

Tiziana Reports Reduction in Brain Inflammation in Third Multiple System Atrophy Patient Treated with Intranasal Foralumab

BOSTON, July 31, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana”), a biotechnology company developing its lead candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, announces quantitative PET imaging results from the third patient with Multiple System Atrophy (MSA) in the Phase 2 clinical trial treated with intranasal foralumab to complete dosing.

Read source ↗
TENX globenewswire.com · about 9 hours ago

Tenax Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Company expects to report topline data from Phase 3 LEVEL clinical trial in August 2026 CHAPEL HILL, N.C., July 31, 2026 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (Nasdaq: TENX) (“Tenax” or “Tenax Therapeutics” or the “Company”) today reported financial results for the quarter ended June 30, 2026 and provided an update on its corporate progress.

Read source ↗
INMB globenewswire.com · about 9 hours ago

INmune Bio Receives R&D Rebates of Approximately $4.6 Million

BOCA RATON, Fla., July 31, 2026 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a late-stage biotechnology company focused on inflammation and immunology, today announced that on July 30, 2026, it received a research and development cash rebate from Australia of approximately $4.2 million.  This rebate is in addition to approximately $0.4 million of rebate from the United Kingdom during June 2026.  After adjusting second-quarter operating cash flows to exclude the approximately $0.4 million rebate received during the quarter, the combined rebate proceeds exceeded the Company's net cash used in operating activities during the quarter.  The rebates strengthen the Company's balance sheet and extend its cash runway as INmune Bio advances CORDStrom™ (Ebstrocel™) toward regulatory filings.

Read source ↗
ATCO businesswire.com · about 9 hours ago

Atlas Energy Solutions Expands AI-Enabled Digital Transformation of Oilfield Logistics with Kodiak-Powered Driverless Trucks

AUSTIN, Texas--(BUSINESS WIRE)--Atlas Energy Solutions Inc. (NYSE: AESI) (“Atlas”), a leading energy solutions provider, today announced an expansion of its autonomous truck operations in the Permian Basin, advancing its commitment to unlocking energy by digitally transforming oilfield logistics.Working with Kodiak AI, Inc. (“Kodiak”) (Nasdaq: KDK), a leading provider of Physical AI-powered autonomous driving technology, Atlas is expanding its driverless proppant delivery program to a second sim.

Read source ↗
RISE globenewswire.com · about 9 hours ago

Green Thumb Expands Pennsylvania Retail Footprint with the Opening of RISE Dispensary Hanover

CHICAGO and VANCOUVER, British Columbia, July 31, 2026 (GLOBE NEWSWIRE) -- RISE Dispensaries, an industry leading cannabis retail chain owned by Green Thumb Industries Inc. ("Green Thumb" or the "Company") (CSE: GTII) (OTCQX: GTBIF), today announced the opening of RISE Dispensary Hanover in Hanover, Pennsylvania. The new RISE store is located at 361 Eisenhower Drive, Hanover, PA 17331.

Read source ↗
EQPT globenewswire.com · about 9 hours ago

INVESTOR NOTICE: EquipmentShare.com, Inc. (EQPT) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces

SAN DIEGO, July 31, 2026 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of EquipmentShare.com, Inc. (NASDAQ: EQPT): (i) Class A common stock pursuant and/or traceable to the registration statement and prospectus issued in connection with EquipmentShare.com's January 2026 initial public offering (“IPO”); and/or (ii) securities between January 23, 2026 and June 23, 2026, both dates inclusive (the “Class Period”), have until September 21, 2026 to seek appointment as lead plaintiff of the EquipmentShare.com class action lawsuit. Captioned Parra v.

Read source ↗
WNRS globenewswire.com · about 9 hours ago

Regeneron Awards $150,000 to Winners of the 2026 Regeneron Prize for Creative Innovation

Early-career scientists from New York University, Stanford University and Rensselaer Polytechnic Institute were recognized for their ambitious "dream project" proposals TARRYTOWN, N.Y., July 31, 2026 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the recipients of the 2026 Regeneron Prize for Creative Innovation (“the Regeneron Prize”).

Read source ↗
INMB globenewswire.com · about 9 hours ago

INmune Bio Receives R&D Rebates of Approximately $4.6 Million

BOCA RATON, Fla. , July 31, 2026 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the "Company"), a late-stage biotechnology company focused on inflammation and immunology, today announced that on July 30, 2026, it received a research and development cash rebate from Australia of approximately $4.

Read source ↗
globenewswire.com · about 9 hours ago

The Orange Giant Announces ZHAI Has Entered Full Production

ABU DHABI, UNITED ARAB EMIRATES, July 31, 2026 (GLOBE NEWSWIRE) -- The Orange Giant, an independent game development studio, announced that ZHAI has entered full production. The milestone moves the third-person open-world action-adventure into an active development phase focused on refining its core mechanics, combat systems and high-fidelity visuals.

Read source ↗
INMB globenewswire.com · about 9 hours ago

INmune Bio Inc. to Report Second Quarter 2026 Financial Results and Provide Corporate Update on Thursday, August 6th

Management to host conference call and webcast at 4:30 pm ET on that day BOCA RATON, Fla, July 31, 2026 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the "Company"), a late-stage biotechnology company focused on inflammation and immunology, today announced t that it will host a conference call on Thursday, August 6th, 2026 at 4:30pm EDT to discuss results for its quarter ended June 30, 2026 and to provide a corporate update.

Read source ↗
← Newer
Older →